Results 51 to 60 of about 23,869 (285)

Icariin Prevents Diabetes-Induced Bone Loss in Rats by Reducing Blood Glucose and Suppressing Bone Turnover

Molecules, 2019
Diabetic Osteoporosis (DOP) is a common metabolic bone disease, characterized by decreased bone mineral density (BMD) and destruction of bone microstructure.
Shanshan Qi, Jia He, Hongxing Zheng, Chen Chen, Shiqiang Lan   +4 more
doaj   +1 more source

Table_1_Identification of ferroptosis-related molecular clusters and genes for diabetic osteoporosis based on the machine learning.xlsx

, 2023
BackgroundDiabetic osteoporosis exhibits heterogeneity at the molecular level. Ferroptosis, a controlled form of cell death brought on by a buildup of lipid peroxidation, contributes to the onset and development of several illnesses.
Lei Meng (1394350), Zhuqiang Jia (2557093), Xueling Qu (3638539), Ming Lu (122276), Xingkai Wang (13861133), Junwei Zong (6816893), Lin Zhao (92451), Zitong Zhao (5264765), Mingzhi Song (16637886), Juewei Zhang (16825410), Linxuan Zou (12566346), Xin Han (1329648), Shouyu Wang (109860)   +12 more
core   +1 more source

The role of wnt signaling in diabetes-induced osteoporosis

Diabetology & Metabolic Syndrome, 2023
Osteoporosis, a chronic complication of diabetes mellitus, is characterized by a reduction in bone mass, destruction of bone microarchitecture, decreased bone strength, and increased bone fragility.
Kairan Bao, Yinghua Jiao, Lei Xing, Fang Zhang, Faming Tian   +4 more
doaj   +1 more source

Table_5_Identification of ferroptosis-related molecular clusters and genes for diabetic osteoporosis based on the machine learning.xlsx

, 2023
BackgroundDiabetic osteoporosis exhibits heterogeneity at the molecular level. Ferroptosis, a controlled form of cell death brought on by a buildup of lipid peroxidation, contributes to the onset and development of several illnesses.
Lei Meng (1394350), Zhuqiang Jia (2557093), Xueling Qu (3638539), Ming Lu (122276), Xingkai Wang (13861133), Junwei Zong (6816893), Lin Zhao (92451), Zitong Zhao (5264765), Mingzhi Song (16637886), Juewei Zhang (16825410), Linxuan Zou (12566346), Xin Han (1329648), Shouyu Wang (109860)   +12 more
core   +1 more source

Catalpol Protects Against High Glucose-Induced Bone Loss by Regulating Osteoblast Function

Frontiers in Pharmacology, 2021
Objective: The overall objective of this study was to investigate the effects of catalpol on bone remodeling of diabetic osteoporosis by regulating osteoblast differentiation and migration.Method: Using a murine model of diabetic osteoporosis, to detect ...
Lu Zhao, Wei Du, Dandan Zhao, Xueyan Ji, Yanfei Huang, Yong Pang, Kaijin Guo, Xiaoxing Yin   +7 more
doaj   +1 more source

Type I diabetic osteoporosis and osteoblast apoptosis

, 2012
TYPE I DIABETIC OSTEOPOROSIS AND OSTEOBLAST APOPTOSIS ByLindsay Martin CoeType I diabetes is a metabolic disorder that affects roughly 1 million people in the United States.
Coe, Lindsay Martin
core   +1 more source

Image3_PPARβ/δ Agonist Alleviates Diabetic Osteoporosis via Regulating M1/M2 Macrophage Polarization.pdf

, 2021
Diabetic osteoporosis is a common complication in diabetic patients, leading to increased fracture risk and impaired bone healing. As a member of the peroxisome proliferator-activated receptor (PPAR) family, PPARβ/δ agonist is suggested as a therapeutic ...
Weimin Lin (2117626), Zhihe Zhao (4034060), Rui Ye (466902), Miao Chen (213356), Jianru Yi (11651807)   +4 more
core   +1 more source

Type 2 diabetes is associated with higher trabecular bone density but lower cortical bone density: the Vietnam Osteoporosis Study

, 2018
© 2018, International Osteoporosis Foundation and National Osteoporosis Foundation. Summary: It is not clear why type 2 diabetes (T2D) has an increased risk of fracture despite higher areal bone mineral density.
Ho-Pham, LT, Nguyen, HC, Chau, PMN, Do, AT, Nguyen, TV   +4 more
core   +1 more source

Image2_PPARβ/δ Agonist Alleviates Diabetic Osteoporosis via Regulating M1/M2 Macrophage Polarization.pdf

, 2021
Diabetic osteoporosis is a common complication in diabetic patients, leading to increased fracture risk and impaired bone healing. As a member of the peroxisome proliferator-activated receptor (PPAR) family, PPARβ/δ agonist is suggested as a therapeutic ...
Weimin Lin (2117626), Zhihe Zhao (4034060), Rui Ye (466902), Miao Chen (213356), Jianru Yi (11651807)   +4 more
core   +1 more source

Image1_PPARβ/δ Agonist Alleviates Diabetic Osteoporosis via Regulating M1/M2 Macrophage Polarization.pdf

, 2021
Diabetic osteoporosis is a common complication in diabetic patients, leading to increased fracture risk and impaired bone healing. As a member of the peroxisome proliferator-activated receptor (PPAR) family, PPARβ/δ agonist is suggested as a therapeutic ...
Weimin Lin (2117626), Zhihe Zhao (4034060), Rui Ye (466902), Miao Chen (213356), Jianru Yi (11651807)   +4 more
core   +1 more source